Measures of Obesity and Co-Morbid Conditions in Maori
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It has been proposed that a higher cut off for BMI (body mass index) is to be used in Maori to define overweight and obesity. However, no one has assessed the prevalence of co-morbid conditions associated with BMI. It is well known that Maori are at greater risk of diabetes and cardiovascular disease compared to non-Maori and a delay in the identification of those who are overweight and obese may be detrimental for Maori. We will assess BMI, other measures of adiposity and prevalence of co-morbid conditions with a comparison with a similar matched non-Maori population.
| Condition |
|---|
|
Body Composition |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Cross-Sectional Time Perspective: Prospective |
| Estimated Enrollment: | 220 |
| Study Start Date: | January 2003 |
| Estimated Study Completion Date: | December 2005 |
This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.
Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.
Eligibility| Ages Eligible for Study: | 18 Years to 68 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Self identify as Maori and non-Maori aged between 18-68 years
- Male and female
- Non-diabetic
- Resident of Dunedin and Invercargill
Exclusion Criteria:
- The presence of diabetes, renal or liver failure, or any other medical condition which is unstable and for which they are currently having active treatment
Contacts and Locations| New Zealand | |
| Edgar National Centre for Diabetes Research | |
| Dunedin, Otago, New Zealand, 9001 | |
| Study Director: | Jim I Mann, FRACP, PhD | Edgar National Centre for Diabetes Research |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00208598 History of Changes |
| Other Study ID Numbers: | ENCDR_3 |
| Study First Received: | September 13, 2005 |
| Last Updated: | September 13, 2005 |
| Health Authority: | New Zealand: Health and Disability Ethics Committees |
Keywords provided by Edgar National Centre for Diabetes Research:
|
Maori Body Composition DEXA Cardiovascular disease Diabetes |
ClinicalTrials.gov processed this record on May 19, 2013